MicroRNA-552 promotes migration and invasion of osteosarcoma through targeting TIMP2

被引:15
作者
Chao, Yu [1 ]
Hu, Kejun [1 ]
Wang, Xueli [2 ]
Wang, Lei [1 ]
机构
[1] Xian Med Univ, Affiliated Hosp 1, Dept Orthopaed, Xian 710077, Shaanxi, Peoples R China
[2] Xian Med Univ, Affiliated Hosp 1, Dept Radiol, Xian 710077, Shaanxi, Peoples R China
关键词
microRNA-552; Osteosarcoma; TIMP2; MMPs; Migration; MATRIX METALLOPROTEINASES; SUPPRESSES; EXPRESSION; MIR-552; CELLS;
D O I
10.1016/j.bbrc.2019.02.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant miRNAs play important roles in tumor development and progression. Previous studies reported that miR-552 was dysregulated expressed in multiple cancers. However, its biological effects and underlying mechanism in osteosarcoma remains largely unknown. In present research, we demonstrated that miR-552 was significantly up-regulated in both osteosarcoma cell lines and tissues for the first time. Its high-expression was significantly associated with poor prognostic features and overall survival of osteosarcoma patients. Gain- and loss-of-function experiment confirmed that miR-552 promoted cell migration, invasion and MMPs expression. Moreover, TIMP2 was a direct downstream target of miR-552. miR-552 inversely correlated with TIMP2 in osteosarcoma tissues. TIMP2 restoration at least partially abolished the migration, invasion and MMPs expression of miR-552 on osteosarcoma cells. Above all, our data suggest that miR-552 promoted migration, invasion and MMPs expression of osteosarcoma by targeting TIMP2, and represent a novel potential therapeutic target for osteosarcoma. (C) 2019 Published by Elsevier Inc.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 28 条
[1]   Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies [J].
Abarrategi, Ander ;
Tornin, Juan ;
Martinez-Cruzado, Lucia ;
Hamilton, Ashley ;
Martinez-Campos, Enrique ;
Rodrigo, Juan P. ;
Victoria Gonzalez, M. ;
Baldini, Nicola ;
Garcia-Castro, Javier ;
Rodriguez, Rene .
STEM CELLS INTERNATIONAL, 2016, 2016
[2]   Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma [J].
Blattmann, Claudia ;
Oertel, Susanne ;
Schulz-Ertner, Daniela ;
Rieken, Stefan ;
Haufe, Sabine ;
Ewerbeck, Volker ;
Unterberg, Andreas ;
Karapanagiotou-Schenkel, Irini ;
Combs, Stephanie E. ;
Nikoghosyan, Anna ;
Bischof, Marc ;
Jaekel, Oliver ;
Huber, Peter ;
Kulozik, Andreas E. ;
Debus, Juergen .
BMC CANCER, 2010, 10
[3]  
Chen G, 2018, EUR REV MED PHARMACO, V22, P5452, DOI 10.26355/eurrev_201809_15805
[4]   MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA [J].
Chen, Hanwen ;
Gao, Shuming ;
Cheng, Cai .
HUMAN CELL, 2018, 31 (04) :300-309
[5]   Causes and consequences of microRNA dysregulation in cancer [J].
Croce, Carlo M. .
NATURE REVIEWS GENETICS, 2009, 10 (10) :704-714
[6]   MicroRNA485-3p negatively regulates the transcriptional co-repressor CtBP1 to control the oncogenic process in osteosarcoma cells [J].
Du, Kaili ;
Zhang, Xinliang ;
Lou, Zhenkai ;
Guo, Peiyu ;
Zhang, Fan ;
Wang, Bing ;
Chen, Lingqiang ;
Zhang, Chunqiang .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018, 14 (11) :1445-1456
[7]  
Errani C, 2011, EXPERT REV ANTICANC, V11, P217, DOI [10.1586/era.10.172, 10.1586/ERA.10.172]
[8]   miRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma [J].
Gao, Gan ;
Tian, Zhen ;
Zhu, Huan-Ye ;
Ouyang, Xun-Yan .
CANCER CELL INTERNATIONAL, 2018, 18
[9]   Tectorigenin inhibits osteosarcoma cell migration through downregulation of matrix metalloproteinases in vitro [J].
Guo, Yu ;
Chen, Ya-Hong ;
Cheng, Zhi-Hua ;
Ou-Yang, Huo-Niu ;
Luo, Cong ;
Guo, Zhi-Lin .
ANTI-CANCER DRUGS, 2016, 27 (06) :540-546
[10]  
Kim J, 2014, ANTICANCER RES, V34, P2297